Cidofovir for recurrent respiratory papillomatosis (RRP): a re-assessment of risks

Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1465-7. doi: 10.1016/j.ijporl.2005.08.007. Epub 2005 Sep 19.
No abstract available

Publication types

  • Editorial
  • Practice Guideline

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use*
  • Carcinogens / administration & dosage*
  • Child
  • Cidofovir
  • Cytosine / analogs & derivatives*
  • Cytosine / therapeutic use
  • Drug Approval
  • Humans
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / virology
  • Organophosphonates / therapeutic use*
  • Papillomavirus Infections / drug therapy*
  • Respiratory Tract Neoplasms / drug therapy*
  • Respiratory Tract Neoplasms / virology
  • Risk Assessment
  • Severity of Illness Index
  • United States
  • United States Food and Drug Administration

Substances

  • Antiviral Agents
  • Carcinogens
  • Organophosphonates
  • Cytosine
  • Cidofovir